Introduction to AMR by Deputy Regional Director ppt, 896kb

Introduction to

Antimicrobial Resistance

Dr Poonam Khetrapal Singh
Deputy Regional Director
1|

Prevention and control of antimicrobial resistance: WHD2011

Outline
What is antimicrobial resistance (AMR) and its
implications?
Why are we worried about AMR in SEA Region?
What are the possible solutions?
What is WHO doing?
What we all can do?
2|

Prevention and control of antimicrobial resistance: WHD2011

Outline
 What is antimicrobial resistance (AMR) and its implications
 Why are we worried about AMR in SEA Region
 What are the possible solutions
 What is WHO doing
 What we all can do

3|

Prevention and control of antimicrobial resistance: WHD2011

Antimicrobial (Antibiotics) resistance
 Resistance is unresponsiveness to antimicrobial agents in
standard doses
 A natural biological unstoppable phenomenon which is driven
by rampant misuse of antimicrobial agents

– 50% of antibiotics are prescribed inappropriately
– 50% of patients have poor compliance
– 50% of populations do not have access to essential antibiotics

– 50% of antibiotics in some countries are used for animal growth promotion
4|

Prevention and control of antimicrobial resistance: WHD2011

Resistance has huge negative impact on health
 Longer duration of illness
 Longer treatment
 Higher mortality
 Treatment with expensive drugs
 Increased burden on health system
 Negates technological advances in medical sector
– Complex surgeries
– Transplantations and other interventions

 Patient acts as reservoir of resistant organisms which are
passed to community and health-care workers
 Huge economic impact on individual and society
5|

Prevention and control of antimicrobial resistance: WHD2011

Outline
 What is antimicrobial resistance (AMR) and its implications
 Why are we worried about AMR in SEA Region
 What are the possible solutions
 What is WHO doing
 What we all can do

6|

Prevention and control of antimicrobial resistance: WHD2011

Resistance is negating “wonder drugs” in SEAR
 Tuberculosis
– MDR-TB < 3% : 130,000 cases annually, XDR-TB: Reported from 4 countries

 Kala-azar
– 60% resistance in pentavalent antimony and 25% in pentamidine

 Typhoid fever
– MDR Salmonella Typhi prevalent all over Region
– Causing 10% Case Fatality Rate (CFR) in children (preantibiotic era: 12.8%)

 Hospital associated infections
– Staphylococcus aureus: >50% isolates in hospitals are methicillin-resistant (MDR)
– Acinetobacter baumannii: >50% of patients infected with resistant strains die
– Pseudomonas, Klebsiella, Serratia: MDR persist in hospital settings, and cause huge mortality
morbidity

 Malaria
– 400 million people at risk of infection with resistant parasite
7|

Prevention and control of antimicrobial resistance: WHD2011

Superbugs* are visible manifestations of our prolonged failure to preserve antibiotics

. Known but neglected
Need immediate action

Known but
inevitable

**8Methicillin
resistant
Staph aureus,
ESBLresistance:
producing Gram
negative bacteria and NDM-1 producing
Prevention
and MDR-and
controlXDR
of Mycobacteria,
antimicrobial
WHD2011
|
enterobacteriaceae bacteria are few examples of superbugs because these fail to respond to large number of commonly used antibiotics

Outline

 What is antimicrobial resistance (AMR) and its implications
 Why are we worried about AMR in SEA Region
 What are the possible solutions
 What is WHO doing
 What we all can do

9|

Prevention and control of antimicrobial resistance: WHD2011

Possible solutions
 Discover new drugs faster than emergence of resistance
 Promote discovery, development and dissemination of new
antimicrobial agents
 Prevent emergence of resistance by reducing selection
pressure by appropriate control measures
 Rationalize the use of available antimicrobial agents

10

Prevention and control of antimicrobial resistance: WHD2011

Antibiotics: Roadway

11

Prevention and control of antimicrobial resistance: WHD2011

Possible solutions
 Discover new drugs faster than emergence of resistance
 Rationalize the use of available antimicrobial agents
 Prevent emergence of resistance by reducing selection
pressure by appropriate control measures
 Promote discovery, development and dissemination of new
antimicrobial agents
Implementation requires a strategy with comprehensive
national initiatives/plans
12

Prevention and control of antimicrobial resistance: WHD2011

Regional Strategy on AMR and Resolution of RC63

 Governance
 Regulatory
 Capacity building
 Community
education
 Research

13

Prevention and control of antimicrobial resistance: WHD2011

Outline
 What is antimicrobial resistance (AMR) and its implications
 Why are we worried about AMR in SEA Region
 What are the possible solutions
 What is WHO doing
 What we all can do

14

Prevention and control of antimicrobial resistance: WHD2011

WHO material for technical support….

Available at www.searo.who.int/AMR

15

Prevention and control of antimicrobial resistance: WHD2011

Outline
 What is antimicrobial resistance (AMR) and its implications
 Why are we worried about AMR in SEA Region
 What are the possible solutions
 What is WHO doing
 What we all can do

16

Prevention and control of antimicrobial resistance: WHD2011

“antimicrobial resistance is
possibly the single biggest
threat facing the world in
the area of infectious diseases”.

Antibiotics are
a precious resource
We need to preserve
this resource by
working together

Use Antibiotics
rationally
17

Prevention and control of antimicrobial resistance: WHD2011